Email updates

Keep up to date with the latest news and content from BMC Immunology and BioMed Central.

Open Access Highly Accessed Research article

Role of CD40 ligation in dendritic cell semimaturation

Anna-Maria Gerlach, Alexander Steimle, Lea Krampen, Alexandra Wittmann, Kerstin Gronbach, Julia Geisel, Ingo B Autenrieth and Julia-Stefanie Frick*

Author Affiliations

Institute for Medical Microbiology and Hygiene, University Hospital of Tübingen, 72076 Elfriede-Aulhorn-Str. 6, Tübingen, D-72076, Germany

For all author emails, please log on.

BMC Immunology 2012, 13:22  doi:10.1186/1471-2172-13-22


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2172/13/22


Received:5 December 2011
Accepted:16 April 2012
Published:26 April 2012

© 2012 Gerlach et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

DC are among the first antigen presenting cells encountering bacteria at mucosal surfaces, and play an important role in maintenance of regular homeostasis in the intestine. Upon stimulation DC undergo activation and maturation and as initiators of T cell responses they have the capacity to stimulate naïve T cells. However, stimulation of naïve murine DC with B. vulgatus or LPS at low concentration drives DC to a semimature (sm) state with low surface expression of activation-markers and a reduced capacity to activate T-cells. Additionally, semimature DC are nonresponsive to subsequent TLR stimulation in terms of maturation, TNF-α but not IL-6 production. Ligation of CD40 is an important mechanism in enhancing DC maturation, function and capacity to activate T-cells. We investigated whether the DC semimaturation can be overcome by CD40 ligation.

Results

Upon CD40 ligation smDC secreted IL-12p40 but not the bioactive heterodimer IL-12p70. Additionally, CD40 ligation of smDC resulted in an increased production of IL-6 but not in an increased expression of CD40. Analysis of the phosphorylation pattern of MAP kinases showed that in smDC the p38 phosphorylation induced by CD40 ligation is inhibited. In contrast, phosphorylation of ERK upon CD40 ligation was independent of the DC maturation state.

Conclusion

Our data show that the semimature differentiation state of DC can not be overcome by CD40 ligation. We suggest that the inability of CD40 ligation in overcoming DC semimaturation might contribute to the tolerogenic phenotype of semimature DC and at least partially account for maintenance of intestinal immune homeostasis.

Keywords:
Dendritic cells; CD40 ligation; Maturation; Cytokine; MAP Kinase; Homoeostasis; T-cell

Background

Dendritic cells (DC) are among the first antigen presenting cells encountering bacteria at mucosal surfaces and play an important role in maintenance of regular homeostasis in the intestine. Stimulation of DC with e.g. TLR agonists leads to activation and maturation of DC by activation of NF-κB and mitogen-activated protein kinase (MAPK) family members [1]. This results in a rapid production of costimulatory molecules, cytokines and pro-inflammatory mediators that affect T-cell differentiation, for instance.

We identified Escherichia coli mpk, a commensal E. coli strain which induces colitis in genetically predisposed hosts and Bacteroides vulgatus mpk which does not elicit colitis and even prevents the colitis caused by E. coli mpk [2,3]. Stimulation of bone marrow derived dendritic cells (BMDC) with E. coli[4] or lipopolysaccharide (LPS) at high concentration [5] induced TNF-α, IL-12 and IL-6 secretion and expression of activation-markers, whereas stimulation with B. vulgatus or [4] LPS at low concentrations [5] only led to secretion of IL-6 and DC were driven to a semimature state with low expression of activation-markers. Those semimature DC were nonresponsive to subsequent TLR stimulation in terms of maturation and TNF-α but not IL-6 production [4,5]. Moreover, the low positive expression of activation surface marker like e.g. CD40 on semimature DC, was not overcome by a subsequent stimulus via TLR4 [4]. This might contribute to the reduced activation of T-cells by semimature DC [4] as binding of the CD40 ligand (CD40L) on naïve T-cells to CD40 is a crucial signal for generation of effective CD4+ and CD8+ T-cell responses [6,7]. CD40 ligation results in upregulation of CD83, CD80 and CD86 as well as MHC molecules on DC. Additionally, the expression of adhesion molecules ICAM-1 and CD58 [8-11] is upregulated and survival of DC is supported by CD40 ligation [12,13]. Furthermore, CD40 ligation of mature DC results in secretion of proinflammatory cytokines e.g. IL-1, IL-6 and IL-12 [9-11][14,15].

IL-12 plays an important role in T-cell polarization by promoting Th-1 responses. Its bioactive heterodimer IL-12p70 consists of a p40 and p35 subunit, which are encoded by different genes and therefore independently regulated. IL-12p40 can also form homodimers (IL-12p80) which were shown to inhibit IL-12p70 mediated immune responses [16,17].

Mitogen-activated protein kinase (MAPK) signal transduction pathways play a crucial role in many aspects of immune mediated inflammatory responses [18]. The MAPK ERK, JNK and p38 are important regulators of host immune responses to e.g. bacterial stimuli. Extracellular stimuli induce phosphorylation of MAPK–kinase-kinase (MKKK) which in turn phosphorylate MKK. Specific MKK are necessary to phosphorylate and activate MAPK, which results in activation of downstream kinases and transcription factors [18-20]. The products of inflammatory genes include e.g. cytokines, chemokines and adhesion molecules which promote recruitment of immunocompetent cells to inflammatory sites. Additionally, the MAPK p38 enhances the mRNA stability of many proinflammatory cytokines, e.g. IL-8, TNF-α or IL-6 [21-23].

Within the present study we analyzed the effects of DC semimaturation on cellular responses to CD40 ligation and showed that the semimature differentiation state of DC, induced by stimulation with B. vulgatus or LPSlo can not be overcome by CD40 ligation.

Methods

Mice

C57Bl/6x129sv mice were obtained from own breeding. All mice were kept under SPF conditions. Male and female mice were sacrificed at 6–12 weeks of age. Animal experiments were reviewed and approved by the responsible institutional review committee (Regierungspräsidium Tübingen, December 19th 2008).

Abs and reagents

Ultra pure LPS Salmonella enterica serovar Minnesota was purchased from Calbiochem (Schwalbach, Germany). The following antibodies were used for flow cytometry: PE conjugated anti-mouse CD11c, clone HL3, Biotin conjugated anti-mouse CD40, clone 3/23, Biotin conjugated anti-mouse CD80, clone 16-10A1, FITC conjugated anti-mouse I-A/I-E clone 2 G9, FITC conjugated anti-mouse CD86, clone GL1. As isotype control hamster IgG1 λ2, hamster IgG2a κ and rat IgG2a κ were used. For CD40 ligation we used purified NA/LE hamster anti-mouse CD40, clone HM40-3, and purified NA/LE hamster IgM, λ1 isotype control, clone G235-1 (all antibodies from BD, Heidelberg, Germany). p38 MAP kinase inhibitor (SB202190) was purchased from Calbiochem (Schwalbach, Germany), and ERK inhibitor (PD98059) from Promega (Mannheim, Germany).

Western blotting

For p38 and pERK Western blot analysis proteins (50 μg) were solubilized in Laemmli sample buffer. They were separated on SDS-PAGE gels and transferred to nitrocellulose membranes. The membranes were blocked for 1 h at room temperature in 5% dry milk in TBS/T (TBS containing 2,01% Tween). After that the membranes were incubated with mouse anti-p38 MAPK (pT180/pY182) or with mouse anti-ERK 1/2 (pT202/pY204) (both BD Pharmigen, Heidelberg, Germany) at 4°C over night. The antibody solution was diluted 1:1000 in 5% dry milk in TBS/T. After incubation the membranes were washed three times in TBS/T and were treated with the secondary antibody (polyclonal rabbit anti-mouse conjugated to horseradish peroxidase, DakoCytomation, Hamburg, Germany; diluted 1:1000 in 5% dry milk in TBS/T) for 2.5 h at room temperature. After repeating the washing step the proteins were detected by enhanced chemiluminescence. Before using ß-actin (mouse anti-mouse β-actin; Sigma, Munich, Germany) as a control for protein loading, the blots were stripped for 20 min with 10 ml stripping-solution (10 mM NaOH and 250 mM guanidinium chloride).

Bacteria and cell lines

The bacteria used for stimulation of the murine dendritic cells were Escherichia coli mpk [2] and Bacteroides vulgatus mpk [2] . The E. coli strain was grown in Luria-Bertani (LB) medium under aerobic conditions at 37°C. Bacteroides vulgatus was grown in Brain-Heart-Infusion (BHI) medium and anaerobic conditions at 37°C. In some experiments, J558L/CD40L cells were used for CD40 ligation. The cells were cultured in DMEM (Dulbecco’s modified Eagle’s medium,Invitrogen, Darmstadt, Germany) supplemented with 1 g/l glucose, L-glutamine, pyruvate, 50 μmol/l 2-mercaptoethanol, 10% FCS and penicillin/streptomycin.

Mouse DC isolation

Bone marrow cells were isolated and cultured as described previously [4] with minor modifications. Cells were harvested at day 7 and used to evaluate the effects of cellular challenge with E. coli mpk, B. vulgatus mpk and LPS on subsequent CD40 ligation. Cytokine release and expression of surface markers were determined after CD40 ligation as described below.

Stimulation of isolated DC

At day 7, DC were stimulated with viable bacteria at a MOI of 1 at 37°C, 5% CO2. Gentamicin was added one hour after stimulation and cells were incubated for 24 hour. To exclude bacterial overgrowth, CFU of viable bacteria was determined at the end of incubation period. Respectively, DC were stimulated with LPS (1 ng/ml and 1 μg/ml). After 24 h cell culture supernatant was harvested for analysis of cytokine expression and cells were used for flow cytometry of surface marker expression.

CD40 ligation

To determine the effects of CD40 ligation on DC cytokine production and expression of surface markers DC were restimulated using an agonistic anti-CD40 mAb (BD, Heidelberg, Germany). Therefore, DCs pretreated with E. coli, B. vulgatus or LPS were harvested, washed twice and cultured at 1.5x105 DC in the presence of 5 μg/ml anti-CD40 mAb in DC culture medium at 37°C, 5% CO2. As a control, DCs were incubated with 5 μg/ml of the IgM isotype control antibody (BD, Heidelberg, Germany). After 48 h, DC culture supernatants were harvested and analyzed for cytokine concentrations by ELISA. The expression of CD80 and CD86 on the DC surface was determined by FACS analysis.

For determination of CD40 expression of DC upon CD40 ligation the J558/LCD40L cell line was irradiated with 180 Gy in a Gammacell 1000 Elite® (Nordion, Ottawa, Canada) prior to co-culture with DC. 5x104 J558L/CD40L cells were cultured with 1.5x105 DC in DC culture medium for 48 h at 37°C, 5% CO2. DC were harvested and analyzed for expression of CD40 by FACS.

Inhibition of MAP kinase signaling

DC were incubated with the p38 MAP kinase inhibitor SB202190 (2 μmol/l) or the ERK inhibitor PD98059 (50 μmol/l) for 30 min prior to CD40 ligation. After 30 min the cells were washed. CD40 ligation with anti CD40 mAb was performed for 24 h. Cell culture supernatants were harvested and used for determination of cytokine concentrations.

Cytokine analysis by ELISA

For analysis of IL-6, IL-12p40 and IL-12p70 concentrations in cell culture supernatants commercially available ELISA kits (BD, Heidelberg, Germany) were used according to the manufacturer’s instructions.

Flow cytometry analysis

3x105 DC were incubated in 150 μl PBS containing 0.5-μl of fluorochrome conjugated antibodies and applied to flow cytometry analysis. 30,000 cells were analyzed using a FACS Calibur (BD, Heidelberg, Germany).

Statistical analysis

Statistical analysis was performed using the two sided unpaired Student’s t-test. P values < 0.05 were considered significant. Error bars represent ± SEM.

Results

CD40 ligation does not overcome DC semimaturation

Stimulation of DC with B. vulgatus or LPSlo (1 ng/ml) leads to induction of DC semimaturation [4,5] whereas stimulation of immature DC with E. coli or LPShi (1 μg/ml) induces DC maturation. The semimature DC phenotype is characterized by tolerance towards a subsequent stimulation via TLR2 or TLR4 in terms of TNF-α and IL-12p70 but not IL-6 secretion and a low positive expression of costimulatory molecules like e.g. CD40, CD80 CD86 [4,5]. Herein we investigated whether CD40 ligation as a TLR independent DC activation signal can overcome the semimature DC phenotype and induce activation and maturation of semimature DC.

By stimulation of immature DC with B. vulgatus or LPSlo we induced semimature DC, and by stimulation with E. coli or LPShi DC maturation was induced. Secretion of IL-12p40 (Figure 1A), IL-12p70 (Figure 1B) and IL-6 (Figure 1C) was determined by ELISA. CD40 ligation of semimature DC led to secretion of IL-12p40 but not to secretion of the bioactive heterodimer IL-12p70. In contrast, CD40 ligation of mature DC resulted in significant enhanced secretion of IL-12p70 as compared to cells treated with the anti-CD40 mAb isotype control. Mature DC revealed a high spontaneous production of IL-12p40 which was only slightly enhanced by CD40 ligation (Figure 1A, B). Additionally, CD40 ligation of semimature DC resulted in increased levels of IL-6 compared to immature DC. In mature DC which also showed a high spontaneous secretion rate of IL-6 CD40 ligation only led to a slight further increase of IL-6 production (Figure 1C).

thumbnailFigure 1 . Cytokine secretion of differentially primed BMDC in response to secondary CD40 ligation. Wildtype BMDC were stimulated with B. vulgatus mpk (MOI 1) or E. coli mpk (MOI 1) and LPS at low (1 ng/ml) or high concentration (1 μg/ml), respectively, for 24 hour. Unstimulated DC (PBS) served as a control. Subsequently, these DC were washed twice and were re-stimulated with an agonistic anti-CD40 mAb (5 μg/ml) for 48 hours (black bars). As a control, DC were further incubated in medium only (white bars) or in the presence of the isotype control (grey bars). The concentrations of IL-12p40 (A), IL-12p70 (B) and IL-6 (C) were determined by ELISA. The bars represent the mean values of three independent experiments, each performed as duplicate, + SD. * p < 0.05, ** p < 0.01, *** p < 0.001.

Next, we investigated whether CD40 ligation can overcome the low positive expression of DC activation markers on semimature DC. Therefore, we analysed the expression of CD80 (Figure 2A), CD86 (Figure 2B), and CD40 (Figure 2C) on immature, mature and semimature DC upon CD40 ligation in comparison to mock cells or cells treated with the anti-CD40 mAb isotype control by FACS.

thumbnailFigure 2 . Expression of CD80, CD86 and CD40 on differentially primed BMDC after secondary CD40 ligation. Wildtype BMDC were stimulated with B. vulgatus mpk (MOI 1) or E. coli mpk (MOI 1) and LPS at low (1 ng/ml) or high concentration (1 μg/ml), respectively, for 24 hours. Unstimulated DCs (PBS) served as a control. Figure2A and 2B: The pre-treated DC were washed twice and were re-stimulated with an agonistic anti-CD40 mAb (5 μg/ml) for 48 hours. As a control, DCs were further incubated in medium only (mock) or in the presence of the isotype control. The expression levels of CD80 (A) and CD86 (B) were measured by FACS analysis. Figure2C: The pre-treated DC were washed twice and were re-stimulated with CD40L by co-culture with J558L/CD40L transfectants or were cultured in medium only as a control (− J558L/CD40L). After 48 hours, the expression of CD40 was determined by FACS analysis. Each histogram is representative of three independent experiments. The data are mean values of the percentages of the positive cell populations determined in these three experiments, ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001; # p < 0.05 compared to the respective control (PBS).

On semimature DC the expression of CD80 was slightly enhanced upon CD40 ligation, as compared to the control cells (mock or isotype treated). However, in comparison to mature DC, in semimature DC the expression of CD80 was still significantly reduced after subsequent CD40 ligation (E. coli 76.7% ± 1.5% vs. B. vulgatus 37.1% ± 0.6%; LPShi 79.0% ± 1.9% vs. LPSlo 53.4% ± 3.7%) (Figure 2A). Analysis of the expression of CD86 on immature, semimature and mature DC upon CD40 ligation revealed a slight increase of CD86 expression in immature (9.1% ± 0.5% to 27.2% ± 4.7%) and semimature DC (B. vulgatus: 20.4% ± 5.1% to 42.5% ± 8.6%; LPSlo 44.3% ± 7.9% to 58.7% ± 9.5%). However, the expression levels of CD86 on semimature DC after CD40 ligation did not reach the expression levels of mature DC (E. coli: 54.8% ± 6.7% to 59.9% ± 6.5%; LPShi 56.6% ± 3.3% to 61.3% ± 5.5%) (Figure 2B).

The MHC class II expression on immature, semimature and mature DC was slightly increased upon CD40 ligation. These changes, however, proved not to be statistically significant (data not shown).

As anti-CD40 antibodies used for ligation assays and anti-CD40 antibodies used for FACS analysis might compete for binding of CD40 we used the J558L/CD40L cell line to analyze the influence of CD40 ligation on the expression of CD40 itself on DC. In B. vulgatus treated semimature DC we found an increase of CD40 expression upon CD40 ligation (B. vulgatus 26.8% ± 7.4% to 55.0% ± 0.1%). In LPSlo treated semimature DC we observed a similar effect, however, the increase in CD40 expression was statistically not significant (57.8% ± 6.6% to 63.5% ± 8.9%). Interestingly, CD40 ligation of semimature DC did not lead to an increase of CD40 resulting in as high expression levels as on mature DC (E. coli 77.1% ± 4.2%; LPShi 75.2% ± 4.0%) (Figure 2C).

In DC semimaturation CD40L induced p38 phosphorylation is inhibited

To analyze phosphorylation of the MAP kinase p38 in response to CD40 ligation, immature, semimature and mature DC were activated by CD40 ligation and pp38 levels were determined by Western blotting. CD40 ligation of immature and mature DC resulted in phosphorylation of p38, whereas in semimature DC p38 phosphorylation upon CD40 ligation slightly reduced (Figure 3).

thumbnailFigure 3 . Phosphorylation of p38 MAPK upon secondary CD40 ligation in immature, semimature and mature DC. Wildtype BMDC were stimulated with B. vulgatus mpk or LPS 1 ng/ml (LPSlow) to generate semimature DC and E. coli mpk or LPS 1 μg/ml (LPShigh), respectively, to generate mature DC. Immature DC were maintained by incubation in the absence of further stimuli (PBS). After 24 hours, DC were re-stimulated with anti-CD40 mAb (1 μg/ml) for 15 minutes or treated with the isotype control (Isotype). The expression of pp38 was analyzed by Western blotting. As loading control, β-actin expression was determined. The results shown are representative of three independent experiments.

To investigate the biological relevance of p38 MAP kinase activation we treated immature, semimature and mature DC with the p38 inhibitor SB202190 prior to CD40 ligation. Levels of IL-12p40, IL-12p70 and IL-6 were determined in cell culture supernatants by ELISA (Figure 4 A-C).

thumbnailFigure 4 . Role of p38 MAPK on CD40L induced cytokine secretion in DC of different maturation status. Wildtype BMDC were primed with B. vulgatus mpk or LPS 1 ng/ml to obtain semimature DC and E. coli mpk or LPS 1 μg/ml, respectively, to obtain mature DC. Immature DC were maintained by incubation in the absence of further stimuli (PBS). Subsequently, the DC were washed and treated with the p38 inhibitor SB202190 (2 μmol/l, black bars) or as a control with DMSO (grey bars) for 30 minutes, washed and re-stimulated with 1 μg/ml anti-CD40 mAb (+) or the isotype control (−). After 24 hours, the concentrations of IL-12p40 (A), IL-12p70 (B) and IL-6 (C) were measured in the cell culture supernatants by ELISA. The bars represent the mean values of three independent experiments, each performed as duplicate, ± SD. * p < 0.05, *** p < 0.001 for SB202190 compared to DMSO.

Inhibition of p38 had no influence on the CD40L induced secretion of IL-12p40 by DC, independent of the maturation state (Figure 4A). However, in mature DC the production of IL-12p70 upon CD40 ligation was inhibited partially by SB202190. Inhibition of p38 did not influence the IL-12p70 expression pattern in immature or semimature DC as CD40 ligation did not induce any IL-12p70 secretion in these cells (Figure 4B). In mature DC, both spontaneous and CD40L induced IL-6 secretion levels were partially reduced by inhibition of the p38 MAP kinase. In contrast, IL-6 production of immature as well as semimature DC upon CD40 ligation was not significantly affected by inhibition of p38 (Figure 4C).

In DC semimaturation ERK suppresses CD40L induced IL-12p40 production

To analyze the role of the extracellular signal regulated kinase (ERK) we used the ERK inhibitor PD98059. Upon CD40 ligation the inhibition of ERK resulted in a significant increase of IL-12p40 in immature and semimature DC but only a slight increase in mature DC (Figure 5A). In contrast, inhibition of ERK had not the ability to induce IL-12p70 production in immature and semimature DC and resulted in only slightly enhanced IL-12p70 secretion levels in mature DC (Figure 5B). The CD40L induced IL-6 production by DC was not affected by ERK inhibition, independent of the maturation state (Figure 5C). In line with this, analysis of pERK levels upon CD40 ligation of immature, semimature and mature DC showed similar levels independent of the DC maturation state (data not shown).

thumbnailFigure 5 . Role of ERK on CD40L induced cytokine secretion in DC of different maturation status. Wildtype BMDC were primed with B. vulgatus mpk or LPS 1 ng/ml to obtain semimature DC and E. coli mpk or LPS 1 μg/ml, respectively, to obtain mature DC. Immature DC were maintained by incubation in the absence of further stimuli (PBS). Subsequently, the DC were washed and treated with the ERK inhibitor PD98059 (50 μmol/l, black bars) or as a control with DMSO (grey bars) for 30 minutes, washed and re-stimulated with 1 μg/ml anti-CD40 mAb (+) or the isotype control (−). After 24 hours, the concentrations of IL-12p40 (A), IL-12p70 (B) and IL-6 (C) were measured in the cell culture supernatants by ELISA. The bars represent the mean values of three independent experiments, each performed as duplicate, ± SD. * p < 0.05 for PD98059 compared to DMSO.

Taken together, our data showed that the semimature differentiation state of DC, induced by stimulation with B. vulgatus or LPSlo can not be overcome by CD40 ligation.

Discussion

In order to clarify the impact of CD40 expression on the T-cell activation capacity of semimature DC, we examined the effect of CD40 ligation on immature, semimature and mature DC. Semimature DC were induced by either stimulation with B. vulgatus or LPS at low concentration (1 ng/ml), and are characterized by a low positive expression of costimulatory molecules like e.g. CD40, secretion of only IL-6, and nonresponsiveness toward subsequent TLR activation [4,5].

In brief, we showed that CD40 ligation does not overcome DC semimaturation in terms of expression of activation surface markers and results in production of only IL-6 and IL-12p40, but not the bioactive form IL-12p70. The slightly reduced p38 phosphorylation levels in semimature DC as compared to mature DC might at least partially contribute to this effect. The expression of IL-12p40 turned out to be limited by pERK.

In line with other studies [24,25], we observed that on mature DCs no significant further increase in the expression levels of the already highly expressed costimulatory molecules CD40, CD80 and CD86 could be triggered upon additional stimulation by CD40 ligation.

Upon CD40 ligation immature and semimature DC expressed intermediate levels of CD40 CD80 and CD86, but did not reach the expression level of mature DC. However, the intermediate expression of costimulatory molecules was not associated with production of pro-inflammatory cytokines like IL-12p70.

It is known that immature DCs characterized by low expression levels of costimulatory molecules and lacking secretion of proinflammatory cytokines induce tolerance by promoting T-cell anergy, apoptosis or differentiation into Treg cells via antigen presentation in the absence of costimulatory signals [26-29]. Additionally, CD40 deficient DCs or DCs with a suppressed CD40 expression were shown to have a reduced potential to activate T-cell proliferation and polarization in Th1 or Th2 direction [30-34]. This effect might also contribute to the inhibited T-cell activation induced by the intermediate expression of costimulatory molecules on semimature lamina propria (lp) DC of B. vulgatus monocolonized IL-2−/− mice [3]. On the other hand it was shown that a high positive expression of costimulatory molecules in absence of pro-inflammatory mediators like e.g. TNF-α or IL-12p70 favours T-cell tolerance and suppression of T-cell activation. This type of DC is mainly induced by autocrine or paracrine stimulation with inflammatory mediators like e. g. TNF-α [35-38].

The cytokine secretion pattern upon CD40 ligation differed between immature/semimature DC and mature DC. In immature and semimature DC, CD40 ligation did not result in induction of IL-12p70 secretion, in contrast to mature DC where CD40 ligation led to increased IL-12p70 secretion. This is in line with other studies showing that TLR4 stimulation and CD40 ligation synergize in inducing IL-12 p70 secretion [25,39]. The additive microbial priming signals are necessary to trigger the production of the IL-12p35 subunit [40] which was shown to be not induced by exclusive CD40 ligation [41,42]. Additionally, these accessory stimuli have the potential to augment the CD40 expression on antigen presenting cells (APC) [43-45] which results in a more effective CD40 ligation. However, DC primed with Bacteroides vulgatus as a microbial stimulus do not secrete IL-12p70 upon CD40 ligation. This might be one mechanism accounting for the tolerogenic effects of B. vulgatus in maintenance of intestinal homeostasis [2,3]. As Porphyromonas gingivalis which is phylogenetically closely related to B. vulgatus signals mainly vial TLR2 [46], this might be also the main receptor for recognition of B. vulgatus. In turn, TLR2 activation is reported to result in transcription of the p40 but not the p35 subunit of IL-12p70 [1,47]. This might account for the induction of IL-12p40 but not p70 upon stimulation of B. vulgatus primed DC via CD40 ligation. The production of IL-12p40 in the absence of the p35 unit might result in the formation of IL-12p40 homodimers which are known to act as potent antagonists at the IL-12p70 receptor [48-50]. Additionally, in IL-12p40 transgenic mice Th1 responses are significantly reduced suggesting that also in vivo p40 functions as an IL-12 antagonist [51].

Upon CD40 ligation semimature DC produced significantly enhanced levels of IL-6 but not TNF-α (data not shown) or IL-12p70. This is in line with our previous studies showing a crucial role for IL-6 in induction of DC semimaturation and tolerance [4,5,52]. This is interesting as the secretion of IL-6 upon CD40 ligation by semimature DC might help to sustain the semimature differentiation state and influence the T-cell activation pattern. IL-6 plays an important role in T-cell differentiation through two independent molecular mechanisms. First, IL-6 stimulation of T-cells leads to an upregulation of nuclear factor of activated T cells (NFAT) [53], a transcription factor regulating IL-4 transcription [54] resulting in IL-4 expression, and thereby promotion of Th2 polarized T cell differentiation [55]. Second, IL-6 upregulates the expression of silencer of cytokine signaling (SOCS) 1 in CD4+ cells which inhibits IFN-γ signaling and thus Th1 differentiation [56]. The presence of IL-6 may shift the Th1/Th2 balance towards Th2 [55].

CD40 ligation of DC is known to result in phosphorylation of MAP kinases like e.g. p38 and ERK [57,58] and the ratio between pp38 and pERK is thought to play a crucial role in directing the cytokine secretion pattern of DC towards pro- or anti-inflammatory host responses [59-61]. CD40 ligation of mature DC resulted in phosphorylation of p38, inhibition of pp38 using the inhibitor SB202190 partially reduced of IL-12p70 and IL-6 but not IL-12p40 levels. Therefore, in mature DC pp38 might contribute to positive regulation of the p35 subunit of IL-12p70 [62]. This is in line with others showing that pp38 is important for production of IL-12p70 [61,63]. Additionally, pp38 is known to increase the stability of IL-6, TNF-α and IL-8 mRNA [22,23,64] which might result in increased secretion of these cytokines. Furthermore, via the mitogen and stress activated protein kinase (MSK) 1 pp38 is involved in NFκB activation [65,66]. In contrast, CD40L induced IL-12p40 secretion from mature DC has been shown to be independent of p38 phosphorylation, but dependent on the NFκB inducing kinase (NIK) [67].

As we observed an only slight reduction of p38 phosphorylation in semimature DC we hypothesize that inhibition of p38 phosphorylation due to DC semimaturation is only one of many factors that may affect in interaction with others the cytokine secretion pattern of semimature dendritic cells in response to secondary CD40 stimulation and thus their reduced pro-inflammatory capability [3-5]. The slight differences in the MAP kinase phosphorylation pattern in response to CD40 ligation might be based on differences in CD40 expression of immature, semimature or mature DC. A strong CD40 signal is known to preferentially activate p38, whereas weak CD40 signals are thought to favour ERK phosphorylation [60].

Inhibition of pERK during CD40 ligation turned out to have no significant effect of cytokine secretion in mature DC. In contrast, in semimature DC phosphorylation of ERK was at least partially responsible for limiting IL-12p40 expression. This is in line with others showing similar effects [68]. However, the Western blot analysis did not reveal significant differences of pERK levels in immature, semimature or mature DC. We speculate that in semimature DC the ERK activation might probably control the IL-12p40 production and therefore contribute to the limitation of the IL-12 p70 production. We are aware that this is highly speculative and that further work has to elucidate the role of ERK in DC semimaturation.

Conclusion

We hypothesize that the inability of CD40 ligation in overcoming DC semimaturation might contribute to the tolerogenic phenotype of semimature DC and at least partially account for maintenance of intestinal homeostasis.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

AMG: Performance of experiments, analysis of data, writing of manuscript, AS: Performance of experiments, analysis of data, LK: Performance of experiments, AW: Performance of experiments, KG: Performance of experiments, JG: Performance of experiments, IBA: Designing of experiment, JSF: Designing of experiment, analysis of data, data interpretation, writing of manuscript. All authors read and approved the final manuscript.

Acknowledgement

This project was funded by the DFG (Deutsche Forschungsgemeinschaft) (FR 2087/6-1), the BMBF (Bundesministerium für Bildung und Forschung) and the IZKF (Interdisziplinäres Zentrum für Klinische Forschung) Promotionskolleg.

References

  1. Re F, Strominger JL: Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells.

    J Biol Chem 2001, 276:37692-37699. PubMed Abstract | Publisher Full Text OpenURL

  2. Waidmann M, Bechtold O, Frick JS, Lehr HA, Schubert S, Dobrindt U, Loeffler J, Bohn E, Autenrieth IB: Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice.

    Gastroenterology 2003, 125:162-177. PubMed Abstract | Publisher Full Text OpenURL

  3. Muller M, Fink K, Geisel J, Kahl F, Jilge B, Reimann J, Mach N, Autenrieth IB, Frick JS: Intestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarization.

    PLoS One 2008, 3:e2376. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  4. Frick JS, Zahir N, Muller M, Kahl F, Bechtold O, Lutz MB, Kirschning CJ, Reimann J, Jilge B, Bohn E, Autenrieth IB: Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: An important role for IL-6.

    Eur J Immunol 2006, 36:1537-1547. PubMed Abstract | Publisher Full Text OpenURL

  5. Geisel J, Kahl F, Muller M, Wagner H, Kirschning CJ, Autenrieth IB, Frick JS: IL-6 and Maturation Govern TLR2 and TLR4 Induced TLR Agonist Tolerance and Cross-Tolerance in Dendritic Cells.

    J Immunol 2007, 179:5811-5818. PubMed Abstract | Publisher Full Text OpenURL

  6. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR: Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

    Nature 1998, 393:478-480. PubMed Abstract | Publisher Full Text OpenURL

  7. Chang WL, Baumgarth N, Eberhardt MK, Lee CY, Baron CA, Gregg JP, Barry PA: Exposure of myeloid dendritic cells to exogenous or endogenous IL-10 during maturation determines their longevity.

    J Immunol 2007, 178:7794-7804. PubMed Abstract | Publisher Full Text OpenURL

  8. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van KC, Durand I, Banchereau J: Activation of human dendritic cells through CD40 cross-linking.

    J Exp Med 1994, 180:1263-1272. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  9. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.

    J Exp Med 1996, 184:747-752. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  10. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E, Romani N, Schuler G: High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10.

    J Exp Med 1996, 184:741-746. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  11. Toso JF, Lapointe R, Hwu P: CD40 ligand and lipopolysaccharide enchance the in vitro generation of melanoma-reactive T-cells.

    J Immunol Methods 2002 Jan 1, 259(1-2):181-190. Publisher Full Text OpenURL

  12. Bjorck P, Banchereau J, Flores-Romo L: CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells.

    Int Immunol 1997, 9:365-372. PubMed Abstract | Publisher Full Text OpenURL

  13. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y: TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

    J Exp Med 1997, 186:2075-2080. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  14. Boonstra A, Rajsbaum R, Holman M, Marques R, sselin-Paturel C, Pereira JP, Bates EE, Akira S, Vieira P, Liu YJ, Trinchieri G, O'Garra A: Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals.

    J Immunol 2006, 177:7551-7558. PubMed Abstract | Publisher Full Text OpenURL

  15. Kuniyoshi JS, Kuniyoshi CJ, Lim AM, Wang FY, Bade ER, Lau R, Thomas EK, Weber JS: Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells.

    Cell Immunol 1999, 193:48-58. PubMed Abstract | Publisher Full Text OpenURL

  16. Holscher C: The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases.

    Med Microbiol Immunol 2004, 193:1-17. PubMed Abstract | Publisher Full Text OpenURL

  17. Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity.

    Nat Rev Immunol 2003, 3:133-146. PubMed Abstract | Publisher Full Text OpenURL

  18. Hommes DW, Peppelenbosch MP, van Deventer SJ: Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets.

    Gut 2003, 52:144-151. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  19. Chang L, Karin M: Mammalian MAP kinase signalling cascades.

    Nature 2001, 410:37-40. PubMed Abstract | Publisher Full Text OpenURL

  20. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

    Science 2002, 298:1911-1912. PubMed Abstract | Publisher Full Text OpenURL

  21. Grassl GA, Kracht M, Wiedemann A, Hoffmann E, Aepfelbacher M, Eichel-Streiber C, Bohn E, Autenrieth IB: Activation of NF-kappaB and IL-8 by Yersinia enterocolitica invasin protein is conferred by engagement of Rac1 and MAP kinase cascades.

    Cell Microbiol 2003, 5:957-971. PubMed Abstract | Publisher Full Text OpenURL

  22. Brook M, Sully G, Clark AR, Saklatvala J: Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade.

    FEBS Lett 2000, 483:57-61. PubMed Abstract | Publisher Full Text OpenURL

  23. Wang SW, Pawlowski J, Wathen ST, Kinney SD, Lichenstein HS, Manthey CL: Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase.

    Inflamm Res 1999, 48:533-538. PubMed Abstract | Publisher Full Text OpenURL

  24. Dohnal AM, Luger R, Paul P, Fuchs D, Felzmann : CD40 ligation restores type 1 polarizing capacity in TLR4-activated dendritic cells that have ceased interleukin-12 expression.

    J Cell Mol Med T 2009, 13:1741-1750. Publisher Full Text OpenURL

  25. Lapointe R, Toso JF, Butts C, Young HA, Hwu P: Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes.

    Eur J Immunol 2000, 30:3291-3298. PubMed Abstract | Publisher Full Text OpenURL

  26. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.

    J Exp Med 2001, 193:233-238. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  27. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo.

    J Exp Med 2001, 194:769-779. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  28. Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells.

    Annu Rev Immunol 2003, 21:685-711. PubMed Abstract | Publisher Full Text OpenURL

  29. van den Broek M: Dendritic cells break bonds to tolerize.

    Immunity 2007, 27:544-546. PubMed Abstract | Publisher Full Text OpenURL

  30. Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM: The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation.

    J Exp Med 2004, 199:1607-1618. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  31. Martin E, O'Sullivan B, Low P, Thomas R: Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10.

    Immunity 2003, 18:155-167. PubMed Abstract | Publisher Full Text OpenURL

  32. Murugaiyan G, Martin S, Saha B: Levels of CD40 expression on dendritic cells dictate tumour growth or regression.

    Clin Exp Immunol 2007, 149:194-202. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  33. Smith DW, Nagler-Anderson C: Preventing intolerance: the induction of nonresponsiveness to dietary and microbial antigens in the intestinal mucosa.

    J Immunol 2005, 174:3851-3857. PubMed Abstract | Publisher Full Text OpenURL

  34. Suzuki M, Zheng X, Zhang X, Ichim TE, Sun H, Kubo N, Beduhn M, Shunnar A, Garcia B, Min WP: Inhibition of allergic responses by CD40 gene silencing.

    Allergy 2009, 64:387-397. PubMed Abstract | Publisher Full Text OpenURL

  35. Joffre O, Nolte MA, Sporri R, Reis e Sousa C: Inflammatory signals in dendritic cell activation and the induction of adaptive immunity.

    Immunol Rev 2009, 227:234-247. PubMed Abstract | Publisher Full Text OpenURL

  36. Lutz MB, Schuler G: Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

    Trends Immunol 2002, 23:445-449. PubMed Abstract | Publisher Full Text OpenURL

  37. Menges M, Rossner S, Voigtlander C, Schindler H, Kukutsch NA, Bogdan C, Erb K, Schuler G, Lutz MB: Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity.

    J Exp Med 2002, 195:15-21. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  38. Sporri R, Reis e Sousa C: Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function.

    Nat Immunol 2005, 6:163-170. PubMed Abstract | Publisher Full Text OpenURL

  39. Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML: High-level IL-12 production by human dendritic cells requires two signals.

    Int Immunol 1998, 10:1593-1598. PubMed Abstract | Publisher Full Text OpenURL

  40. Schulz O, Edwards AD, Schito M, Aliberti J, Manickasingham S, Sher A, Reis e Sousa C: CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal.

    Immunity 2000, 13:453-462. PubMed Abstract | Publisher Full Text OpenURL

  41. Kato T, Hakamada R, Yamane H, Nariuchi H: Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction.

    J Immunol 1996, 156:3932-3938. PubMed Abstract | Publisher Full Text OpenURL

  42. Morelli AE, Zahorchak AF, Larregina AT, Colvin BL, Logar AJ, Takayama T, Falo LD, Thomson AW: Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation.

    Blood 2001, 98:1512-1523. PubMed Abstract | Publisher Full Text OpenURL

  43. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK: CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

    J Exp Med 1993, 178:669-674. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  44. Nguyen VT, Benveniste EN: Critical role of tumor necrosis factor-alpha and NF-kappa B in interferon-gamma -induced CD40 expression in microglia/macrophages.

    J Biol Chem 2002, 277:13796-13803. PubMed Abstract | Publisher Full Text OpenURL

  45. Wesemann DR, Dong Y, O'Keefe GM, Nguyen VT, Benveniste EN: Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages.

    J Immunol 2002, 169:2354-2360. PubMed Abstract | Publisher Full Text OpenURL

  46. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ: Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

    J Immunol 2000, 165:618-622. PubMed Abstract | Publisher Full Text OpenURL

  47. Re F, Strominger JL: IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells.

    J Immunol 2004, 173:7548-7555. PubMed Abstract | Publisher Full Text OpenURL

  48. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J: Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity.

    J Immunol 1995, 154:116-127. PubMed Abstract | Publisher Full Text OpenURL

  49. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK: Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist.

    Eur J Immunol 1995, 25:200-206. PubMed Abstract | Publisher Full Text OpenURL

  50. Nigg AP, Zahn S, Ruckerl D, Holscher C, Yoshimoto T, Ehrchen JM, Wolbing F, Udey MC, von Stebut E: Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice.

    J Immunol 2007, 178:7251-7258. PubMed Abstract | Publisher Full Text OpenURL

  51. Yoshimoto T, Wang CR, Yoneto T, Waki S, Sunaga S, Komagata Y, Mitsuyama M, Miyazaki J, Nariuchi H: Reduced T helper 1 responses in IL-12 p40 transgenic mice.

    J Immunol 1998, 160:588-594. PubMed Abstract | Publisher Full Text OpenURL

  52. Frick JS, Grunebach F, Autenrieth IB: Immunomodulation by semi-mature dendritic cells: A novel role of Toll-like receptors and interleukin-6.

    Int J Med Microbiol 2010, 300(1):19-24. PubMed Abstract | Publisher Full Text OpenURL

  53. Diehl S, Chow CW, Weiss L, Palmetshofer A, Twardzik T, Rounds L, Serfling E, Davis RJ, Anguita J, Rincon M: Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation.

    J Exp Med 2002, 196:39-49. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  54. Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, Afkarian M, Murphy TL: Signaling and transcription in T helper development.

    Annu Rev Immunol 2000, 18:451-494. PubMed Abstract | Publisher Full Text OpenURL

  55. Diehl S, Rincon M: The two faces of IL-6 on Th1/Th2 differentiation.

    Mol Immunol 2002, 39:531-536. PubMed Abstract | Publisher Full Text OpenURL

  56. Diehl S, Anguita J, Hoffmeyer A, Zapton T, Ihle JN, Fikrig E, Rincon M: Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1.

    Immunity 2000, 13:805-815. PubMed Abstract | Publisher Full Text OpenURL

  57. Aicher A, Shu GL, Magaletti D, Mulvania T, Pezzutto A, Craxton A, Clark EA: Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells.

    J Immunol 1999, 163:5786-5795. PubMed Abstract | Publisher Full Text OpenURL

  58. Yu Q, Kovacs C, Yue FY, Ostrowski MA: The role of the p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and phosphoinositide-3-OH kinase signal transduction pathways in CD40 ligand-induced dendritic cell activation and expansion of virus-specific CD8+ T cell memory responses.

    J Immunol 2004, 172:6047-6056. PubMed Abstract | Publisher Full Text OpenURL

  59. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, Koh A, Maliszewski C, Akira S, Pulendran B: A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.

    J Immunol 2004, 172:4733-4743. PubMed Abstract | Publisher Full Text OpenURL

  60. Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B: Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses.

    Nat Med 2004, 10:540-544. PubMed Abstract | Publisher Full Text OpenURL

  61. Mukherjee P, Chauhan VS: Plasmodium falciparum-free merozoites and infected RBCs distinctly affect soluble CD40 ligand-mediated maturation of immature monocyte-derived dendritic cells.

    J Leukoc Biol 2008, 84:244-254. PubMed Abstract | Publisher Full Text OpenURL

  62. Goodridge HS, Harnett W, Liew FY, Harnett MM: Differential regulation of interleukin-12 p40 and p35 induction via Erk mitogen-activated protein kinase-dependent and -independent mechanisms and the implications for bioactive IL-12 and IL-23 responses.

    Immunology 2003, 109:415-425. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  63. Lu HT, Yang DD, Wysk M, Gatti E, Mellman I, Davis RJ, Flavell RA: Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice.

    EMBO J 1999, 18:1845-1857. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  64. Clark AR, Dean JL, Saklatvala J: Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38.

    FEBS Lett 2003, 546:37-44. PubMed Abstract | Publisher Full Text OpenURL

  65. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Haegeman G: p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.

    J Biol Chem 1998, 273:3285-3290. PubMed Abstract | Publisher Full Text OpenURL

  66. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G: Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).

    EMBO J 2003, 22:1313-1324. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  67. Yanagawa Y, Onoe K: Distinct regulation of CD40-mediated interleukin-6 and interleukin-12 productions via mitogen-activated protein kinase and nuclear factor kappaB-inducing kinase in mature dendritic cells.

    Immunology 2006, 117:526-535. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  68. Kikuchi K, Yanagawa Y, Iwabuchi K, Onoe K: Differential role of mitogen-activated protein kinases in CD40-mediated IL-12 production by immature and mature dendritic cells.

    Immunol Lett 2003, 89:149-154. PubMed Abstract | Publisher Full Text OpenURL